向美国毒物中心报告的接触δ-8 四氢大麻酚、δ-10 四氢大麻酚和四氢大麻酚-O 乙酸酯的情况

IF 3 3区医学 Q2 TOXICOLOGY

Clinical Toxicology Pub Date : 2024-04-30 DOI:10.1080/15563650.2024.2340115

Alice Burgess, Hannah L. Hays, Jaahnavi Badeti, Henry A. Spiller, Natalie I. Rine, Christopher E. Gaw, Kele Ding, Gary A. Smith

引用次数: 0

摘要

自 2018 年《农业法案》通过以来，合成四氢大麻酚的供应量有所增加，包括δ-8 四氢大麻酚、δ-10 四氢大麻酚和四氢...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America’s Poison Centers

Since the passage of the Farm Bill in 2018, the availability of synthetic tetrahydrocannabinols has increased, including delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydroc...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Toxicology 医学-毒理学

CiteScore

5.70

自引率

12.10%

发文量

148

审稿时长

4-8 weeks

期刊介绍： clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology, the European Association of Poisons Centres and Clinical Toxicologists, the American Association of Poison Control Centers and the Asia Pacific Association of Medical Toxicology and, as such, is the leading international journal in the specialty.